Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.6K Sell
1,613
-12
-0.7% -$186 ﹤0.01% 457
2026
Q1
$22K Buy
1,625
+12
+0.7% +$168 ﹤0.01% 426
2025
Q4
$20.1K Sell
1,613
-19
-1% -$205 ﹤0.01% 413
2025
Q3
$16.2K Buy
1,632
+19
+1% +$185 ﹤0.01% 357
2025
Q2
$14.4K Sell
1,613
-35,921
-96% -$304K ﹤0.01% 368
2025
Q1
$327K Buy
37,534
+35,921
+2,227% +$377K 0.01% 283
2024
Q4
$20.1K Hold
1,613
﹤0.01% 388
2024
Q3
$18.7K Hold
1,613
﹤0.01% 365
2024
Q2
$16.8K Hold
1,613
﹤0.01% 429
2024
Q1
$19.3K Buy
+1,613
New +$19.4K ﹤0.01% 428

Other funds holding VTRS

Allianz's VTRS Position: Q2 2026 in Review

Allianz reduced its Viatris (VTRS) stake by 0.74% in Q2 2026, selling an estimated $186 and leaving 1,613 shares worth $25.6K. The position accounts for ﹤0.01% of the portfolio, ranked #457.

Allianz first reported a position in VTRS in Q1 2024 and has held it in 10 quarters since. The position peaked at $327K in Q1 2025. 1,026 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Allianz held 1,613 shares of Viatris worth $25.6K as of Q2 2026.
  • Allianz sold 12 Viatris shares in Q2 2026, an estimated $186.
  • Viatris made up ﹤0.01% of Allianz's portfolio in Q2 2026, its #457 holding.
  • Allianz first reported a position in Viatris in Q1 2024 and has held it in 10 quarters since.
  • Allianz's Viatris position peaked at $327K in Q1 2025.
  • 1,026 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.